The Rubidium-82 Generator industry trends have accelerated through 2023-24 as cardiac PET imaging rebounds post-pandemic. In March 2024, Curium acquired the Eczacıbaşı-Monrol generator portfolio, consolidating nearly one-third of global installed capacity and shifting service models toward integrated dose-on-demand contracts. Bracco countered in July 2023 by unveiling a next-gen ZeoRuby generator with 30 % longer column life and Bluetooth-based tracer-level reporting, already adopted by 120 U.S. outpatient centers seeking to reduce 30-day repeat scans. Regulatory momentum is equally brisk: FDA’s December 2023 draft guidance now allows 68-hour on-site eluate storage, effectively doubling provider scheduling flexibility and spurring IBA Molecular to fast-track its 2025 modular generator designed for micro-hospitals. Meanwhile, CMS finalized the AMB payment add-on (C-codes) for Rb-82 PET MPI as of January 2024, lifting reimbursement 18 % and catalyzing a $55 million Series C round for CardioNav to deploy 40 AI-driven mobile generators across underserved Sun-Belt states. Collectively, these moves signal a pivot from capital sales to imaging-as-a-service, with lifecycle analytics bundled into per-patient fees.
